Does DACLIZUMAB Cause Transplant rejection? 385 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 385 reports of Transplant rejection have been filed in association with DACLIZUMAB. This represents 13.8% of all adverse event reports for DACLIZUMAB.
385
Reports of Transplant rejection with DACLIZUMAB
13.8%
of all DACLIZUMAB reports
3
Deaths
8
Hospitalizations
How Dangerous Is Transplant rejection From DACLIZUMAB?
Of the 385 reports, 3 (0.8%) resulted in death, 8 (2.1%) required hospitalization, and 126 (32.7%) were considered life-threatening.
Is Transplant rejection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACLIZUMAB. However, 385 reports have been filed with the FAERS database.
What Other Side Effects Does DACLIZUMAB Cause?
Alopecia (450)
Transplant dysfunction (421)
Acne (382)
Ovarian cyst (374)
Multiple sclerosis relapse (313)
Drug ineffective (229)
Pain (224)
Pneumonia (213)
Condition aggravated (172)
Liver function test abnormal (159)
What Other Drugs Cause Transplant rejection?
TACROLIMUS (3,526)
MYCOPHENOLATE MOFETIL (2,500)
PREDNISONE (1,111)
CYCLOSPORINE (903)
PREDNISOLONE (860)
METHYLPREDNISOLONE (779)
SIROLIMUS (698)
BASILIXIMAB (554)
MYCOPHENOLIC ACID (445)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (437)
Which DACLIZUMAB Alternatives Have Lower Transplant rejection Risk?
DACLIZUMAB vs DACOMITINIB
DACLIZUMAB vs DACTINOMYCIN
DACLIZUMAB vs DALBAVANCIN
DACLIZUMAB vs DALFAMPRIDINE
DACLIZUMAB vs DALTEPARIN